Skip to content

Company information lookup

ALCHEMIA LIMITED (ACL)

The development of carbohydrate-based molecules for therapeutic applications.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
ACL 0.595 -0.83% 0.595 0.600 0.600 0.605 0.595 816,202

ALCHEMIA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code ACL
Securities
Official Listing Date 23 December, 2003
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Registered Office Address Brisbane Technology Park, 3 Hi-Tech Court, EIGHT MILE PLAINS, QLD, AUSTRALIA, 4113
Head Office Telephone (07) 3340 0200
Head Office Fax (07) 3340 0200
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Santo Costa (Non Exec. Chairman)
Mr Thomas Liquard (CEO)
Mr Nathan Drona (Non Exec. Director)
Mr Timothy Hughes (Non Exec. Director)
Dr Susan Kelley (Non Exec. Director)
Dr Tracie Ramsdale (Non Exec. Director)
Company Secretary Mr Stephen Denaro
Principal Activities The development of carbohydrate-based molecules for therapeutic applications.

ALCHEMIA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
14/08/2014   Appendix 3B 8 PDF
01/08/2014   Investor Briefing 33 PDF
30/07/2014   Change in substantial holding from HHL 5 PDF
29/07/2014 asterix Appendix 4C - quarterly 5 PDF
19/06/2014 asterix CHIME Trial First Patient Enrolled 2 PDF
05/06/2014 asterix HA-Irinotecan Phase III Trial Timeline Update 2 PDF
03/06/2014   Change in substantial holding from HHL 5 PDF
30/05/2014   Fondaparinux Investor Update 6 PDF
30/05/2014 asterix Fondaparinux Quarterly Profit Share 2 PDF
02/05/2014   Initial Substantial Holding from HHL 8 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Aug 2014 0.600 0% 0.605 0.590 1,234,199
20 Aug 2014 0.600 2.56% 0.610 0.590 346,069
19 Aug 2014 0.585 0% 0.595 0.585 368,009
18 Aug 2014 0.585 0.86% 0.595 0.575 362,780
15 Aug 2014 0.580 3.57% 0.590 0.560 3,942,015

* Volume of shares shown represents only those shares traded on ASX.

ALCHEMIA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACL

Warrants & Structured Products

No warrants & Structured Products are available over the security ACL

ASX CFDs

No Contracts For Differences are available over the security ACL